Ocular absorption and irritation of pilocarpine prodrug is modified with buffer, polymer, and cyclodextrin in the eyedrop
- PMID: 7596987
- DOI: 10.1023/a:1016297728396
Ocular absorption and irritation of pilocarpine prodrug is modified with buffer, polymer, and cyclodextrin in the eyedrop
Abstract
The influence of buffer, viscosity and cyclodextrin on the ocular absorption and irritation of a pilocarpine prodrug, O,O'-dipropionyl-(1,4-xylylene) bispilocarpic acid diester, was studied in albino rabbits. The prodrug solutions, equivalent to 0.5% pilocarpine, were prepared in 0, 10, 20, 50, or 75 mM citrate buffer at pH 5.0. Viscosity of the solutions (20, 50 or 115 cP) was modified with hydroxypropyl methylcellulose. 2-hydroxypropyl-beta-cyclodextrin (HPCD) was included at concentrations 5, 10 and 15% (w/v). The formulations were compared to a commercial pilocarpine eyedrop (1.7%). Ocular irritation was graded in a double-masked experiment and miosis was used as a bioassay for pilocarpine delivery to the iris. The prodrug showed decreased peak and prolonged duration of miosis compared to pilocarpine, but it caused ocular irritation. Increasing buffer strength decreased and elevated viscosity intensified the miotic response and irritation by the pilocarpine prodrug. HPCD decreased both the ocular delivery of pilocarpine and the irritation by the prodrug, but the net effect was positive. Thus, administering 1.0% of pilocarpine as a prodrug with 15% (w/v) HPCD, the irritation was at the same level with the commercial pilocarpine eyedrop, but the ocular delivery was substantially improved. In conclusion, the ocular delivery of the pilocarpine prodrug may be enhanced in relation to its local irritation by properly combining buffer, viscosity and HPCD.
Similar articles
-
Sulfobutyl ether beta-cyclodextrin (SBE-beta-CD) in eyedrops improves the tolerability of a topically applied pilocarpine prodrug in rabbits.J Ocul Pharmacol Ther. 1995 Summer;11(2):95-106. doi: 10.1089/jop.1995.11.95. J Ocul Pharmacol Ther. 1995. PMID: 8564640
-
Modified beta-cyclodextrin (SBE7-beta-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits.J Pharm Pharmacol. 1996 Mar;48(3):263-9. doi: 10.1111/j.2042-7158.1996.tb05914.x. J Pharm Pharmacol. 1996. PMID: 8737051
-
Miotic effect and irritation potential of pilocarpine prodrug incorporated into a submicron emulsion vehicle.Int J Pharm. 1999 Jul 5;184(1):115-20. doi: 10.1016/s0378-5173(99)00106-4. Int J Pharm. 1999. PMID: 10425357
-
Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye.Acta Ophthalmol Scand. 2002 Apr;80(2):144-50. doi: 10.1034/j.1600-0420.2002.800205.x. Acta Ophthalmol Scand. 2002. PMID: 11952479 Review.
-
Supramolecular cyclodextrin complex: Diversity, safety, and applications in ocular therapeutics.Exp Eye Res. 2019 Dec;189:107829. doi: 10.1016/j.exer.2019.107829. Epub 2019 Oct 9. Exp Eye Res. 2019. PMID: 31605685 Review.
Cited by
-
Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovir.AAPS PharmSciTech. 2003;4(3):E45. doi: 10.1208/pt040345. AAPS PharmSciTech. 2003. PMID: 14621977 Free PMC article.
-
Polysaccharides in Ocular Drug Delivery.Pharmaceutics. 2019 Dec 24;12(1):22. doi: 10.3390/pharmaceutics12010022. Pharmaceutics. 2019. PMID: 31878298 Free PMC article. Review.
-
Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery.Molecules. 2007 Mar 8;12(3):373-88. doi: 10.3390/12030373. Molecules. 2007. PMID: 17851396 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous